Heron Therapeutics | HRTX - Trade Debtors


Heron Therapeutics reported $89.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
ALKERMES USD 456.48M 48.85M Jun/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amarin USD 126.83M 477K Dec/2025
ANI Pharmaceuticals USD 274.47M 19.04M Jun/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
Eisai JPY 253.13B 26.12B Jun/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 215.32M 36.77M Jun/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 12.21B 435M Mar/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 887M 118.9M Jun/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 132.42M 6.78M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Veracyte USD 54.18M 4.06M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026